衰老關(guān)鍵蛋白1(FBLN1)重組蛋白
Recombinant Fibulin 1 (FBLN1)
- 編號RPC472Mu01
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預(yù)測分子量21.3kDa
- 實際分子量25kDa(差異分析請參閱說明書)
- 片段與標簽Cys399~Arg578 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl, pH8.0, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 97%
- 等電點5.8
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 768 ¥ 1920 ¥ 3840 ¥ 11520 ¥ 28800
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure. Gene Sequencing (Extract)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPC472Mu01 | 衰老關(guān)鍵蛋白1(FBLN1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC472Mu01 | 衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體 | WB; IHC; ICC; IP. |
| LAC472Mu71 | 衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| MAC472Mu22 | 衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體 | WB; IHC; ICC; IP. |
| MAC472Mu21 | 衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體 | WB; IHC; ICC; IP. |
| LAC472Mu72 | 衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體(生物素標記) | WB; IHC; ICC. |
| SEC472Mu | 衰老關(guān)鍵蛋白1(FBLN1)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMC472Mu | 衰老關(guān)鍵蛋白1(FBLN1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| PSC472Mu01 | 衰老關(guān)鍵蛋白1(FBLN1)抗體對 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| KSC472Mu01 | 衰老關(guān)鍵蛋白1(FBLN1)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| Clin Exp Metastasis. | Augmented expression of urokinase plasminogen activator and extracellular matrix proteins associates with multiple myeloma progression [Pubmed:24807734] |
| Proteomics Clinical Applications | Comparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients [Pubmed:26680509] |
| PROTEOMICS?-?Clinical?Applications | Comparative mass spectrometric and immunoassay-based?proteome?analysis?in?serum?ofDuchenne muscular dystrophy?patients. [pubmed:26680509] |
| ENVIRONMENTAL RESEARCH | Exploration of identifying novel serum biomarkers for malignant mesothelioma using iTRAQ combined with 2D-LC-MS/MS [Pubmed: 33197421] |
留言咨詢
